Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Nu Holdings
NU
|
+$91.9M |
| 2 |
SW
Smurfit Westrock plc
SW
|
+$76.1M |
| 3 |
Pinduoduo
PDD
|
+$30.9M |
| 4 |
Microsoft
MSFT
|
+$24.9M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$22.8M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$122M |
| 2 |
Apple
AAPL
|
+$45.4M |
| 3 |
WRK
WestRock Company
WRK
|
+$38.2M |
| 4 |
Danaher
DHR
|
+$29M |
| 5 |
Flutter Entertainment
FLUT
|
+$20.3M |
Sector Composition
| 1 | Technology | 32.64% |
| 2 | Healthcare | 12.18% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 9.2% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Recursion Pharmaceuticals
RXRX
$2.12B
| $2.35M | ﹤0.01% |
357,100
+1,900
| +0.5% | +$12.5K |
|
1777
Delek US
DK
$1.72B
| $2.35M | ﹤0.01% |
125,291
-900
| -0.7% | -$16.9K |
|
1778
MGP Ingredients
MGPI
$603M
| $2.33M | ﹤0.01% |
28,000
-200
| -0.7% | -$16.7K |
|
|
AIV
1779
Aimco
AIV
$1.08B
| $2.32M | ﹤0.01% |
256,384
| – | – |
|
1780
Arvinas
ARVN
$573M
| $2.32M | ﹤0.01% |
94,000
| – | – |
|
1781
Arlo Technologies
ARLO
$1.81B
| $2.31M | ﹤0.01% |
190,500
+10,700
| +6% | +$130K |
|
1782
Rocket Pharmaceuticals
RCKT
$354M
| $2.3M | ﹤0.01% |
124,600
| – | – |
|
1783
WK Kellogg Co
KLG
$1.99B
| $2.3M | ﹤0.01% |
134,200
-1,000
| -0.7% | -$17.1K |
|
1784
Opendoor
OPEN
$7.74B
| $2.3M | ﹤0.01% |
1,147,500
+11,300
| +1% | +$22.6K |
|
1785
Schrodinger
SDGR
$1.38B
| $2.29M | ﹤0.01% |
123,600
| – | – |
|
1786
Kaiser Aluminum
KALU
$1.25B
| $2.29M | ﹤0.01% |
31,600
| – | – |
|
1787
TeraWulf
WULF
$4.34B
| $2.29M | ﹤0.01% |
488,800
+43,000
| +10% | +$201K |
|
1788
Middlesex Water
MSEX
$971M
| $2.28M | ﹤0.01% |
34,962
| – | – |
|
|
BBT
1789
Beacon Financial Corporation
BBT
$2.2B
| $2.28M | ﹤0.01% |
84,500
-1,300
| -2% | -$35K |
|
1790
Caleres
CAL
$532M
| $2.27M | ﹤0.01% |
68,600
-600
| -0.9% | -$19.8K |
|
1791
German American Bancorp
GABC
$1.54B
| $2.26M | ﹤0.01% |
58,350
| – | – |
|
1792
SSR Mining
SSRM
$4.62B
| $2.26M | ﹤0.01% |
397,400
-3,700
| -0.9% | -$21K |
|
1793
Steelcase
SCS
$1.95B
| $2.24M | ﹤0.01% |
166,100
| – | – |
|
1794
Pitney Bowes
PBI
$1.97B
| $2.24M | ﹤0.01% |
314,200
+2,000
| +0.6% | +$14.3K |
|
1795
Comstock Resources
CRK
$4.69B
| $2.24M | ﹤0.01% |
201,200
| – | – |
|
1796
Dave & Buster's
PLAY
$796M
| $2.24M | ﹤0.01% |
65,673
-1,700
| -3% | -$57.9K |
|
|
ZUO
1797
DELISTED
Zuora, Inc.
ZUO
| $2.24M | ﹤0.01% |
259,300
+1,800
| +0.7% | +$15.5K |
|
1798
MaxLinear
MXL
$1.4B
| $2.23M | ﹤0.01% |
154,273
+1,300
| +0.8% | +$18.8K |
|
1799
Enact Holdings
ACT
$5.79B
| $2.23M | ﹤0.01% |
61,400
-1,700
| -3% | -$61.8K |
|
1800
Owens & Minor
OMI
$423M
| $2.23M | ﹤0.01% |
142,000
-1,100
| -0.8% | -$17.3K |
|